ATE332702T1 - Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen - Google Patents
Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungenInfo
- Publication number
- ATE332702T1 ATE332702T1 AT96934021T AT96934021T ATE332702T1 AT E332702 T1 ATE332702 T1 AT E332702T1 AT 96934021 T AT96934021 T AT 96934021T AT 96934021 T AT96934021 T AT 96934021T AT E332702 T1 ATE332702 T1 AT E332702T1
- Authority
- AT
- Austria
- Prior art keywords
- glu
- treatment
- production
- associated diseases
- medicinal product
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53870195A | 1995-10-03 | 1995-10-03 | |
US08/614,764 US5902790A (en) | 1995-10-03 | 1996-03-13 | Pharmaceutical angiostatic dipeptide compositions and method of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE332702T1 true ATE332702T1 (de) | 2006-08-15 |
Family
ID=27065900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96934021T ATE332702T1 (de) | 1995-10-03 | 1996-10-02 | Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen |
Country Status (23)
Country | Link |
---|---|
US (4) | US5902790A (de) |
EP (1) | EP0869808B1 (de) |
JP (2) | JP3679129B2 (de) |
KR (1) | KR100483779B1 (de) |
CN (1) | CN1128636C (de) |
AT (1) | ATE332702T1 (de) |
AU (1) | AU714846B2 (de) |
BR (1) | BR9610838A (de) |
CA (1) | CA2233457C (de) |
CZ (1) | CZ298345B6 (de) |
DE (1) | DE69636343T2 (de) |
DK (1) | DK0869808T3 (de) |
EA (1) | EA001146B1 (de) |
ES (1) | ES2268710T3 (de) |
HU (1) | HUP9902105A3 (de) |
IL (1) | IL123889A0 (de) |
MX (1) | MX9802564A (de) |
NO (1) | NO326298B1 (de) |
NZ (1) | NZ319907A (de) |
PL (1) | PL186123B1 (de) |
SK (1) | SK283677B6 (de) |
TR (1) | TR199800653T1 (de) |
WO (1) | WO1997012625A1 (de) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5902790A (en) * | 1995-10-03 | 1999-05-11 | Cytran, Inc. | Pharmaceutical angiostatic dipeptide compositions and method of use thereof |
US6060452A (en) * | 1996-03-13 | 2000-05-09 | Cytran, Inc. | Analogs of L-Glu-L-Trp having pharmacological activity |
AU3467099A (en) * | 1998-04-03 | 1999-10-25 | Cytran Ltd. | Methods for production of therapeutic cytokines |
CA2774959C (en) | 2000-08-04 | 2016-05-31 | Dmi Biosciences, Inc. | Method of using diketopiperazines and composition containing them |
US7229969B2 (en) * | 2001-01-02 | 2007-06-12 | Imtm Gmbh | Combinations of enzyme inhibitors and the use thereof |
DE10100052A1 (de) * | 2001-01-02 | 2002-07-11 | Inst Medizintechnologie Magdeb | Kombinierte Verwendung von Enzyminhibitoren und pharmazeutischen Zubereitungen daraus zur Therapie und Prophylaxe der Atheriosklerose |
US20030087830A1 (en) * | 2001-06-12 | 2003-05-08 | Eric Dupont | Low molecular weight components of cartilage, complexes of metals with amino acids, DI-peptides and analogs thereof; processes for preparation and therapeutic uses thereof |
JP2007500747A (ja) | 2003-05-15 | 2007-01-18 | ディーエムアイ バイオサイエンシズ インコーポレイテッド | T細胞媒介性疾患の処置 |
WO2005016326A2 (en) * | 2003-07-11 | 2005-02-24 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Analogs of thalidomide as potential angiogenesis inhibitors |
US8952895B2 (en) | 2011-06-03 | 2015-02-10 | Apple Inc. | Motion-based device operations |
SG133603A1 (en) | 2003-09-17 | 2007-07-30 | Us Gov Health & Human Serv | Thalidomide analogs as tnf-alpha modulators |
EP1848541A4 (de) * | 2005-02-07 | 2013-01-16 | Pharmalight Inc | Verfahren und vorrichtung zur ophthalmischen verabreichung von pharmazeutischen wirksstoffen |
CA2569204A1 (en) * | 2006-11-28 | 2008-05-28 | Apotex Technologies Inc. | Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl-d-tryptophan |
CA2571645A1 (en) | 2006-12-19 | 2008-06-19 | Apotex Technologies Inc. | Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture |
CN101657210A (zh) * | 2007-02-13 | 2010-02-24 | 希克龙制药公司 | 粘膜疾病引起的组织退化、损伤或损害的治疗或预防方法 |
CA2579119C (en) * | 2007-02-16 | 2013-03-05 | Apotex Technologies Inc. | Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
JP2010536854A (ja) * | 2007-08-23 | 2010-12-02 | サイクローン・ファーマシューティカルズ・インコーポレイテッド | 肺ガンの治療 |
JP5856843B2 (ja) | 2008-05-27 | 2016-02-10 | アンピオ ファーマシューティカルズ,インコーポレイテッド | ジケトピペラジンを用いた医薬組成物 |
DE102008032828A1 (de) * | 2008-07-02 | 2010-01-07 | Technische Universität Dresden | Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel |
CA2810844C (en) | 2010-09-07 | 2017-03-21 | Dmi Acquisition Corp. | Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions |
SG10201608087WA (en) | 2011-10-10 | 2016-11-29 | Ampio Pharmaceuticals Inc | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
EP2766029B1 (de) | 2011-10-10 | 2020-03-25 | Ampio Pharmaceuticals, Inc. | Behandlung degenerativer gelenkerkrankungen |
MX355446B (es) | 2011-10-28 | 2018-04-18 | Ampio Pharmaceuticals Inc | Tratamiento de rinitis. |
US8927725B2 (en) | 2011-12-02 | 2015-01-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Thio compounds |
CN102631464B (zh) * | 2012-05-18 | 2013-07-31 | 崔新明 | 一种治疗婴幼儿血管瘤的中药膏剂及其制备方法 |
CA2906864A1 (en) | 2013-03-15 | 2014-09-18 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
KR20170045274A (ko) | 2014-08-18 | 2017-04-26 | 앰피오 파마슈티컬스 인코퍼레이티드 | 관절 징후의 치료 |
US9925233B2 (en) | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9750785B2 (en) | 2015-01-30 | 2017-09-05 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744239B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744209B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9687526B2 (en) | 2015-01-30 | 2017-06-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US11389512B2 (en) | 2015-06-22 | 2022-07-19 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
JP2020532586A (ja) | 2017-08-31 | 2020-11-12 | シンガポール ヘルス サービシーズ プライベート リミテッド | 網膜血管性疾患の処置のためのangio−3 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH611878A5 (de) * | 1974-07-04 | 1979-06-29 | Takeda Chemical Industries Ltd | |
US4191753A (en) * | 1978-11-06 | 1980-03-04 | University Of Miami | Anti-hypertensive peptide analogs |
ATE78696T1 (de) * | 1987-12-30 | 1992-08-15 | Vsesojuznyj Kardiologitsches | Arzneimittelzubereitung zur behandlung des immunmangels. |
US5728680A (en) * | 1987-12-30 | 1998-03-17 | Cytoven J.V. | Methods for normalizing numbers of lymphocytes |
GR1000608B (el) * | 1988-07-21 | 1992-08-31 | Erba Carlo Spa | Μεθοδος για την παρασκευη ανταγωνιστων bombesin. |
SU1642398A1 (ru) * | 1988-12-21 | 1991-04-15 | Ростовский медицинский институт | Способ лечени синуитов у детей |
US5902790A (en) * | 1995-10-03 | 1999-05-11 | Cytran, Inc. | Pharmaceutical angiostatic dipeptide compositions and method of use thereof |
US5770576A (en) * | 1989-08-30 | 1998-06-23 | Cytran, Inc. | Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity |
RU1827255C (ru) * | 1990-10-22 | 1993-07-15 | Киевский государственный институт усовершенствования врачей | Способ лечени туберкулеза легких |
JP3068656B2 (ja) * | 1991-03-07 | 2000-07-24 | アピ株式会社 | 新規なペプチド及びアンジオテンシン変換酵素阻害ペプチド並びにそれらを含有する経口摂食組成物 |
CA2107460A1 (en) * | 1991-04-01 | 1992-10-02 | Vladimir K. Khavinson | Pharmaceutical dipeptide compositions and methods of use thereof |
RU2014063C1 (ru) * | 1991-04-23 | 1994-06-15 | Сочинский научно-исследовательский институт курортологии и физиотерапии | Способ лечения подострых воспалительных заболеваний гениталий |
JPH07503456A (ja) * | 1991-10-28 | 1995-04-13 | サイトラン・リミテッド | 医薬的ジペプチド組成物およびその使用法 |
WO1995003067A1 (en) * | 1993-07-21 | 1995-02-02 | Khavinson Vladimir Khatskelevi | Pharmaceutical with immunomodulating activity |
EP1333034B1 (de) * | 1993-09-24 | 2010-07-14 | University Of Southern California | Verwendung von Angiotensin-II-Analogen zur Gewebewiederherstellung |
-
1996
- 1996-03-13 US US08/614,764 patent/US5902790A/en not_active Expired - Lifetime
- 1996-10-02 AT AT96934021T patent/ATE332702T1/de not_active IP Right Cessation
- 1996-10-02 AU AU72540/96A patent/AU714846B2/en not_active Expired
- 1996-10-02 SK SK423-98A patent/SK283677B6/sk not_active IP Right Cessation
- 1996-10-02 PL PL96326149A patent/PL186123B1/pl unknown
- 1996-10-02 WO PCT/US1996/015856 patent/WO1997012625A1/en active IP Right Grant
- 1996-10-02 CA CA002233457A patent/CA2233457C/en not_active Expired - Lifetime
- 1996-10-02 ES ES96934021T patent/ES2268710T3/es not_active Expired - Lifetime
- 1996-10-02 BR BR9610838-0A patent/BR9610838A/pt not_active Application Discontinuation
- 1996-10-02 EP EP96934021A patent/EP0869808B1/de not_active Expired - Lifetime
- 1996-10-02 HU HU9902105A patent/HUP9902105A3/hu unknown
- 1996-10-02 IL IL12388996A patent/IL123889A0/xx unknown
- 1996-10-02 EA EA199800357A patent/EA001146B1/ru not_active IP Right Cessation
- 1996-10-02 DK DK96934021T patent/DK0869808T3/da active
- 1996-10-02 JP JP51441597A patent/JP3679129B2/ja not_active Expired - Lifetime
- 1996-10-02 DE DE69636343T patent/DE69636343T2/de not_active Expired - Lifetime
- 1996-10-02 NZ NZ319907A patent/NZ319907A/xx not_active IP Right Cessation
- 1996-10-02 TR TR1998/00653T patent/TR199800653T1/xx unknown
- 1996-10-02 CN CN96197430A patent/CN1128636C/zh not_active Expired - Lifetime
- 1996-10-02 CZ CZ0091398A patent/CZ298345B6/cs not_active IP Right Cessation
- 1996-10-02 KR KR1019980702431A patent/KR100483779B1/ko not_active IP Right Cessation
-
1998
- 1998-03-30 NO NO19981436A patent/NO326298B1/no not_active IP Right Cessation
- 1998-04-01 MX MX9802564A patent/MX9802564A/es unknown
-
1999
- 1999-03-01 US US09/260,190 patent/US6096713A/en not_active Expired - Lifetime
-
2000
- 2000-02-17 US US09/506,430 patent/US6911431B1/en not_active Expired - Fee Related
-
2005
- 2005-03-15 JP JP2005074079A patent/JP2005194287A/ja not_active Withdrawn
- 2005-05-16 US US11/129,367 patent/US20060094665A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE332702T1 (de) | Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen | |
DE69428268T2 (de) | Verwendung von lokalanaesthetika zur herstellung eines arzneimittels zur behandlung von bronchialasthma | |
DE69713526D1 (de) | Lösliche prodrugs von paclitaxel | |
DE69636085D1 (de) | Verwendung von gamma-Linolensäure oder Dihomogammalinolensäure zur Herstellung eines Medikaments zur Behandlung von Huntington's Chorea | |
DE3876877T2 (de) | Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus. | |
ATE185268T1 (de) | Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin | |
ATE205086T1 (de) | Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit | |
ATE353645T1 (de) | Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia | |
DE69713620D1 (de) | Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia | |
ATE194497T1 (de) | Monoklonale antikoerper gegen lfa-1 zur herstellung eines arzneimittels zur vorbeugung der transplantatabstossung von organen | |
DE59508961D1 (de) | Verwendung von weihrauch zur behandlung der alzheimer-krankheit | |
ATE206914T1 (de) | Verwendung von ursolsäure zur herstellung eines arzneimittels zur unterdrückung von metastasen | |
DE69130679D1 (de) | Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation | |
DE3686520D1 (de) | Verwendung von einigen alkanoyl-l-carnitinen zur herstellung eines arzneimittels zur therapeutischen behandlung von ideopathischem oder induziertem parkinsonismus. | |
ATE192650T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
DE68905657T2 (de) | Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen. | |
ATE194076T1 (de) | Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen | |
ATE239492T1 (de) | Verwendung von einem bpi protein zur herstellung eines medikamentes zur behandlung von chronischen herzerkrankungen | |
ATE186640T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung neurogenerativer erkrankungen | |
DE69701258T2 (de) | Verwendung von benzonaphtalene-derivaten zur herstellung eines arzneimittels zur behandlung von krankheiten des nervensystems | |
DE345883T1 (de) | Verwendung von dapiprazol zur herstellung eines arzneimittels zur verhinderung des toleranzentwicklung bei der analgetischen behandlung mit morphin. | |
DE69610045D1 (de) | Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen | |
ATE263565T1 (de) | Verwendung von 8,9-dehydroestron zur herstellung eines arzneimittels zur behandlung von durch freie radikale verursachte krankheiten | |
DE69428797D1 (de) | Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden | |
DE69223811D1 (de) | Verwendung eines homöopathisches Erzeugnisses zur Herstellung eines Arzneimittels für die Behandlung von metabolischen Krankheiten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |